Immunosupressive therapy for primary biliary cirrhosis
- 31 January 1992
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 14 (1) , 1-6
- https://doi.org/10.1016/0168-8278(92)90123-7
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- RELATION BETWEEN ESCHERICHIA COLI R(ROUGH)-FORMS IN GUT, LIPID A IN LIVER, AND PRIMARY BILIARY CIRRHOSISThe Lancet, 1989
- ARE ANTIMITOCHONDRIAL ANTIBODIES IN PRIMARY BILIARY CIRRHOSIS INDUCED BY R(ROUGH)-MUTANTS OF ENTEROBACTERIACEAE?The Lancet, 1988
- Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosisHepatology, 1988
- Primary Biliary CirrhosisNew England Journal of Medicine, 1987
- Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosisHepatology, 1986
- ABERRANT EXPRESSION OF HLA-DR ANTIGENS ON BILEDUCT EPITHELIUM IN PRIMARY BILIARY CIRRHOSIS: RELEVANCE TO PATHOGENESISThe Lancet, 1984
- Primary Biliary Cirrhosis: A Model Autoimmune DiseaseAnnals of Internal Medicine, 1983
- A Prospective Trial of D-Penicillamine in Primary Biliary CirrhosisNew England Journal of Medicine, 1982
- D-PENICILLAMINE TREATMENT IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSISThe Lancet, 1981
- Suppressor cell activity in primary biliary cirrhosisDigestive Diseases and Sciences, 1980